RCSB Protein Data Bank: Enabling biomedical research and drug discovery.

Analyses of publicly available structural data reveal interesting insights into the impact of the three-dimensional (3D) structures of protein targets important for discovery of new drugs (e.g., G-protein-coupled receptors, voltage-gated ion channels, ligand-gated ion channels, transporters, and E3 ubiquitin ligases). The Protein Data Bank (PDB) archive currently holds > 155,000 atomic-level 3D structures of biomolecules experimentally determined using crystallography, nuclear magnetic resonance spectroscopy, and electron microscopy. The PDB was established in 1971 as the first open-access, digital-data resource in biology, and is now managed by the Worldwide PDB partnership (wwPDB; wwPDB.org). US PDB operations are the responsibility of the Research Collaboratory for Structural Bioinformatics PDB (RCSB PDB). The RCSB PDB serves millions of RCSB.org users worldwide by delivering PDB data integrated with ∼40 external biodata resources, providing rich structural views of fundamental biology, biomedicine, and energy sciences. Recently published work showed that the PDB archival holdings facilitated discovery of ∼90% of the 210 new drugs approved by the US Food and Drug Administration 2010-2016. We review user-driven development of RCSB PDB services, examine growth of the PDB archive in terms of size and complexity, and present examples and opportunities for structure-guided drug discovery for challenging targets (e.g., integral membrane proteins). © 2019 The Protein Society.

Citation

David S Goodsell, Christine Zardecki, Luigi Di Costanzo, Jose M Duarte, Brian P Hudson, Irina Persikova, Joan Segura, Chenghua Shao, Maria Voigt, John D Westbrook, Jasmine Y Young, Stephen K Burley. RCSB Protein Data Bank: Enabling biomedical research and drug discovery. Protein science : a publication of the Protein Society. 2020 Jan;29(1):52-65

Mesh Tags

Substances

PMID: 31531901

search → result